Icu Medical Inc (NASDAQ:ICUI) Institutional Investors Sentiment Index Flat in 2016 Q4

July 17, 2017 - By Hazel Jackson

 Icu Medical Inc (NASDAQ:ICUI) Institutional Investors Sentiment Index Flat in  2016 Q4

Sentiment for Icu Medical Inc (NASDAQ:ICUI)

Icu Medical Inc (NASDAQ:ICUI) institutional sentiment decreased to 0.98 in 2016 Q4. Its down -0.05, from 1.03 in 2016Q3. The ratio has worsened, as 104 investment professionals increased and started new equity positions, while 106 decreased and sold their positions in Icu Medical Inc. The investment professionals in our partner’s database now hold: 14.84 million shares, up from 13.95 million shares in 2016Q3. Also, the number of investment professionals holding Icu Medical Inc in their top 10 equity positions increased from 1 to 2 for an increase of 1. Sold All: 21 Reduced: 85 Increased: 65 New Position: 39.

ICU Medical, Inc. is engaged in the development, manufacture and sales of medical devices used in infusion therapy, oncology and critical care applications. The company has market cap of $3.48 billion. The Company’s product line includes needlefree connection devices, custom infusion sets, closed system transfer devices for the handling of hazardous drugs, advanced sensor catheters, needlefree closed blood sampling systems, disposable pressure transducer systems and hemodynamic monitoring systems. It has a 31.74 P/E ratio. The primary critical care products it makes are Hemodynamic Monitoring Systems, SafeSet Closed Blood Sampling and Conservation System, Transpac Consumable Blood Pressure Transducers and Other Critical Care Products.

The stock increased 0.17% or $0.3 during the last trading session, reaching $173.25. About 69,453 shares traded. ICU Medical, Incorporated (NASDAQ:ICUI) has risen 61.84% since July 17, 2016 and is uptrending. It has outperformed by 45.14% the S&P500.

Scholtz & Company Llc holds 2.39% of its portfolio in ICU Medical, Incorporated for 18,654 shares. Elk Creek Partners Llc owns 212,575 shares or 2.11% of their US portfolio. Moreover, Timpani Capital Management Llc has 2.09% invested in the company for 34,139 shares. The New York-based Pura Vida Investments Llc has invested 1.22% in the stock. Monarch Partners Asset Management Llc, a Massachusetts-based fund reported 90,699 shares.#img1#

Since January 1, 0001, it had 1 buying transaction, and 11 selling transactions for $11.13 million activity.

ICU Medical, Incorporated (NASDAQ:ICUI) Ratings Coverage

Ratings analysis reveals 100% of ICU Medical’s analysts are positive. Out of 4 Wall Street analysts rating ICU Medical, 4 give it “Buy”, 0 “Sell” rating, while 0 recommend “Hold”. The lowest target is $124 while the high is $142. The stock’s average target of $130.80 is -24.50% below today’s ($173.25) share price. ICUI was included in 8 notes of analysts from August 11, 2015. The rating was maintained by Roth Capital on Tuesday, August 11 with “Buy”. The stock has “Overweight” rating by Piper Jaffray on Tuesday, August 11. Gabelli initiated ICU Medical, Incorporated (NASDAQ:ICUI) on Friday, March 11 with “Buy” rating. The rating was upgraded by Zacks to “Hold” on Monday, August 17. TH Capital maintained it with “Buy” rating and $124 target in Tuesday, August 11 report. As per Friday, November 6, the company rating was maintained by TH Capital. Roth Capital maintained ICU Medical, Incorporated (NASDAQ:ICUI) on Friday, November 6 with “Buy” rating.

More notable recent ICU Medical, Incorporated (NASDAQ:ICUI) news were published by: Globenewswire.com which released: “ICU Medical Completes the Acquisition of Hospira Infusion Systems from Pfizer” on February 06, 2017, also Globenewswire.com with their article: “ICU Medical, Inc. to Present at the 29th Annual ROTH Conference” published on March 07, 2017, Globenewswire.com published: “ICU Medical, Inc. Provides Update on Hospira Infusion Systems Transaction” on January 05, 2017. More interesting news about ICU Medical, Incorporated (NASDAQ:ICUI) were released by: Nasdaq.com and their article: “ICU Medical, Inc. Announces Time of Second Quarter 2017 Earnings Call” published on July 11, 2017 as well as Wsj.com‘s news article titled: “ICU Medical To Buy Pfizer Unit in $1 Billion Deal” with publication date: October 06, 2016.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.